SPY378.65+2.95 0.79%
DIA309.32+1.20 0.39%
IXIC13,197.18+198.68 1.53%

Morgan Stanley Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $77

Morgan Stanley maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the price target from $73 to $77.

Benzinga · 01/17/2020 13:31

Morgan Stanley maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the price target from $73 to $77.